Using mucolytics in the management of COPD symptoms |
Sputum production is a common feature of chronic obstructive pulmonary disease (COPD), but for some patients, it is difficult to clear, leaving them potentially vulnerable to respiratory infections.
This resource will examine the rationale for mucolytic therapy in the management of patients with COPD. It will discuss the use of mucolytic therapies based on current evidence, and where the use of mucolytics is recommended in international and UK COPD guidelines. |